Cancer Research and Treatment

Original Article

Gastrointestinal cancer

Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis: Yuan Zhang, Lufei Zhang, Sinan Lu, Yucheng Xiang, Cheng Zeng, Tianyu He, Yuan Ding, Weilin Wang; Cancer Res Treat. 2021;53(1):184-198. Published online October 5, 2020; DOI: https://doi.org/10.4143/crt.2020.192

Abstract PDF Supplementary Material PubReader ePub

Purpose
Intrahepatic cholangiocarcinoma (ICC) is one of the most common liver primary tumors but its treatments are limited. Bioinformatics showed that the expression level of long non-coding RNA cancer-associated susceptibility 15 gene (CASC15) is correlated with ICC progression, but its functional mechanism remains unclear.
Materials and Methods
Tissues from ICC patients, tumor and adjacent tissue, were used for detection of the expression of CASC15. Clinical data were also collected for clinicopathologic and survival analysis. Short interfering RNA and lentiviral short hairpin RNA were used to knock down CASC15 and PRDX2 expression in ICC cell lines, for the analysis of changes of cell function and xenografts. RNA-pulldown and RNA immunoprecipitation assays were used to detect RNA-binding protein, PRDX2. Male nude mice were used for ICC xenografts, and livers were collected after 4 weeks for immunohistochemistry.
Results
CASC15 is highly expressed in ICC tissues and is related to higher TNM stage. Knockdown of CASC15 in ICC cells reduced cell proliferation, migration, invasiveness and increased apoptosis, and G1/S block. PRDX2 bound to CASC15. Knockdown of CASC15 decreased PRDX2 expression which was rescued by the inhibition of proteasome formation. Downregulation of PRDX2 resulted in G1/S block, reduced ICC cell invasion. Downregulation of CASC15 inhibited phosphoinositide 3-kinase (PI3K)/AKT/c-Myc pathway through downregulating of PRDX2 and overexpressed PRDX2 rescued the block. CASC15 knockout in ICC xenografts suppressed tumor development in vivo, decreased the expression of PRDX2 and Ki67 and inhibited PI3K/AKT pathway.
Conclusion
CASC15 promotes ICC possibly by targeting PRDX2 via the PI3K/AKT pathway, indicating poor prognosis and high degree of malignancy of ICC.

Citations

Citations to this article as recorded by

A novel interpretable machine learning framework integrating clinicopathological and radiomic features for early recurrence prediction in mass-forming intrahepatic cholangiocarcinoma
Xiao-li Deng, Chongze Yang, Lan-hui Qin, Xue-feng Lin, Fen Zhong, Jin-yuan Liao
Cancer Imaging.2026;[Epub] CrossRef
CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia
Yao Lu, Zhongxian Zhu, Yufei Zhu, Wei Zhu, Ruyi Zhang, Zequan Ding, Hua Xie, Weibing Tang
Digestive Diseases and Sciences.2026;[Epub] CrossRef
Mechanisms of Action and Biomarker Potential of ncRNAs in Hepatocellular Carcinoma and Liver Fibrosis: A Review
Eun Jung Sohn, Sae-Ock Oh, Suraiya Saleem
Analytical Cellular Pathology.2026;[Epub] CrossRef
Mri-based Ki-67 prediction for intrahepatic cholangiocarcinoma: Risk stratification and treatment efficacy prediction
Beixuan Zheng, Lingsong Zhou, Kai Liu, Jing Han, Bin Wang, Ruofan Sheng, Mengsu Zeng
European Journal of Radiology.2026; 199: 112790. CrossRef
Involvement of the PRDX family and its clinical functions in different types of gastrointestinal cancer (Review)
Zhou Zhang, Yujie Wang, Yuhao Liu, Haizhen Wu, Xiaopeng Xu, Kai Wang, Chen He, Chen Qian
Oncology Reports.2025; 54(2): 1. CrossRef
Advances in Multi-Omics Research on Biomarkers of Intrahepatic Cholangiocarcinoma
Jingxue Yang, Jintong Na, Tieliu Shi, Xiyu Liu
Current Issues in Molecular Biology.2025; 47(11): 905. CrossRef
The LINC00519/hsa- miR- 22- 3p/MECOM Axis Accelerates Intrahepatic Cholangiocarcinoma Progression through PI3K/AKT Signaling
Zhuxin Gu, Yanjun Sun, Fajing Chen, Weiwei Gu, Xiaohua Lu, Suming Zhao, Qinan Geng, Yang Yang
Molecular Cancer Research.2025; 23(11): 913. CrossRef
The functions of circular RNAs and long noncoding RNAs in cholangiocarcinoma
Zhangdi Yan, Lixin Du, Xiaotong Zhang, Yunjia Liu, Yuankun Zhang, Jian Deng, Zongli Zhang, Yongchang Tang
Discover Oncology.2025;[Epub] CrossRef
Exploring the mechanism of LncRNA CASC15 affecting hepatocellular carcinoma through miRNA
Qingshan Cai, Dongyang Wu, Yueling Shen, Shudong Li, Liyou Liu, Dong Liu, Yong Li, Xiaonan Chen, Limin Wang, Jianxing Zheng
Medicine.2024; 103(5): e35859. CrossRef
The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma
Mete Ucdal, Ayse Burus, Basak Celtikci
International Journal of Hepatobiliary and Pancreatic Diseases.2024; 14(2): 1. CrossRef
Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review)
Xiaoyu Zhang, Lei Shi, Mengzhen Xing, Chunjing Li, Fengjun Ma, Yuning Ma, Yuxia Ma
International Journal of Molecular Medicine.2024;[Epub] CrossRef
A review on the role of ncRNAs in the pathogenesis of cholangiocarcinoma
Soudeh Ghafouri-Fard, Arash Safarzadeh, Bashdar Mahmud Hussen, Mohammad Taheri, Majid Samsami
International Journal of Biological Macromolecules.2023; 225: 809. CrossRef
A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic Tumor
Bin Chang, Zhe Wang, Min Ren, Qianlan Yao, Lu Zhao, Xiaoyan Zhou
International Journal of Gynecological Pathology.2023; 42(5): 451. CrossRef
Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics
Xianling Qian, Changwu Zhou, Fang Wang, Xin Lu, Yunfei Zhang, Lei Chen, Mengsu Zeng
La radiologia medica.2023; 128(3): 274. CrossRef
Non-Coding RNA in Cholangiocarcinoma: An Update
Jiehan Li, Haolin Bao, Ziyue Huang, Zixin Liang, Ning Lin, Chunjie Ni, Yi Xu
Frontiers in Bioscience-Landmark.2023;[Epub] CrossRef
A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis
Weiwei Chen, Wenqi Qian, Jun Nie, Mintao Dai
Clinical and Experimental Medicine.2022;[Epub] CrossRef
Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma
Yanhua Wu, Khizar Hayat, Yufei Hu, Jianfeng Yang
Frontiers in Cell and Developmental Biology.2022;[Epub] CrossRef
Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway
Ziyan Chen, Bangjie He, Jungang Zhao, Jiacheng Li, Yifeng Zhu, Leilei Li, Wenming Bao, Jiuyi Zheng, Haitao Yu, Gang Chen
Phytomedicine.2022; 104: 154323. CrossRef
Cystic angiomatosis in children: clinical experience and review of literature
Wen Chao Li, Li Liu, Zhen Dong Wang, Hui Chen, Guang Liu, Zhi Chun Feng
World Journal of Surgical Oncology.2022;[Epub] CrossRef
A Study on Mesoporous Silica Loaded With Novel Photosensitizers HCE6 and Oxaliplatin for the Treatment of Cholangiocarcinoma
Pei-Jian Zhang, Meng-Dong Liu, Fang-Yong Fan, Ke-Xia Liu
Frontiers in Oncology.2021;[Epub] CrossRef
LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151–5p/WNT7A axis
Dongfang Bai, Chong Guo, Aimin Wang, Guolong Pang, Jing Gao, Chuan Wang, Dapeng Zhao, Jie Yang, Jianmin Ren
Pathology - Research and Practice.2021; 225: 153561. CrossRef
LncRNA CASC15 Promotes Cerebral Ischemia/Reperfusion Injury via miR-338-3p/ETS1 Axis in Acute Ischemic Stroke
Chen Chen, Linjing Wang, Li Wang, Qi Liu, Chunying Wang
International Journal of General Medicine.2021; Volume 14: 6305. CrossRef
Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma
Li Guo, Yuyang Dou, Yifei Yang, Shiqi Zhang, Yihao Kang, Lulu Shen, Lihua Tang, Yaodong Zhang, Changxian Li, Jun Wang, Tingming Liang, Xiangcheng Li
Computational and Structural Biotechnology Journal.2021; 19: 5722. CrossRef

9,728 View
181 Download
23 Web of Science
23 Crossref

First
Prev
Page of 1
Next
Last

Search